437 results on '"Raisman-Vozari, Rita"'
Search Results
2. Doxycycline Therapeutic Approach in Parkinson’s Disease and L-DOPA-Induced Dyskinesia
3. C9‐Functionalized Doxycycline Analogs as Drug Candidates to Prevent Pathological α‐Synuclein Aggregation and Neuroinflammation in Parkinson's Disease Degeneration.
4. The two synthetic cannabinoid compounds 4′‐F‐CBD and HU‐910 efficiently restrain inflammatory responses of brain microglia and astrocytes
5. Doxycycline Therapeutic Approach in Parkinson’s Disease and L-DOPA-Induced Dyskinesia
6. Cannabidiol prevents haloperidol-induced vacuos chewing movements and inflammatory changes in mice via PPARγ receptors
7. The two synthetic cannabinoid compounds 4′‐F‐CBD and HU‐910 efficiently restrain inflammatory responses of brain microglia and astrocytes.
8. The Neuroprotective Effect of Doxycycline on Neurodegenerative Diseases
9. CMT-3 targets different α-synuclein aggregates mitigating their toxic and inflammogenic effects
10. Enhancing Inhibition of Both α-Synuclein Aggregation and Neuroinflammation: New Insights into the C-9 Modification of Doxycycline
11. The Pesticide Chlordecone Promotes Parkinsonism-like Neurodegeneration with Tau Lesions in Midbrain Cultures and C. elegans Worms
12. Tetracycline repurposing in neurodegeneration: focus on Parkinson’s disease
13. Design and Synthesis of New Non-Antibiotic Doxycyclin Derivatives Against alpha-Synuclein Aggregation with Anti-Inflammatory Properties
14. Rescue of Dopamine Neurons from Iron-Dependent Ferroptosis by Doxycycline and Demeclocycline and Their Non-Antibiotic Derivatives
15. Dynamic Involvement of Striatal NG2-glia in L-DOPA Induced Dyskinesia in Parkinsonian Rats: Effects of Doxycycline
16. Dopaminergic Neurons in Parkinson’s Disease
17. Neuroprotective effects of a brain permeant 6-aminoquinoxaline derivative in cell culture conditions that model the loss of dopaminergic neurons in Parkinson disease
18. Review of: "Effects of the SARS-CoV-2 Spike protein on in vitro aggregation of alpha synuclein- probable molecular interactions and clinical implications"
19. Doxycycline attenuates l-DOPA-induced dyskinesia through an anti-inflammatory effect in a hemiparkinsonian mouse model
20. Effects of a New Natural Catechol-O-methyl Transferase Inhibitor on Two In Vivo Models of Parkinson’s Disease
21. Succinobucol, a Non-Statin Hypocholesterolemic Drug, Prevents Premotor Symptoms and Nigrostriatal Neurodegeneration in an Experimental Model of Parkinson’s Disease
22. Are cyclooxygenase-2 and nitric oxide involved in the dyskinesia of Parkinson's disease induced by L-DOPA?
23. Neuroprotective Effects of a Novel Demeclocycline Derivative Lacking Antibiotic Activity: From a Hit to a Promising Lead Compound
24. Structural Characterization of Heparin-induced Glyceraldehyde-3-phosphate Dehydrogenase Protofibrils Preventing α-Synuclein Oligomeric Species Toxicity
25. Exploiting the therapeutic potential of ready-to-use drugs: Repurposing antibiotics against amyloid aggregation in neurodegenerative diseases
26. Aminochrome induces dopaminergic neuronal dysfunction: a new animal model for Parkinson’s disease
27. Doxycycline Suppresses Microglial Activation by Inhibiting the p38 MAPK and NF-kB Signaling Pathways
28. CX3CR1 Disruption Differentially Influences Dopaminergic Neuron Degeneration in Parkinsonian Mice Depending on the Neurotoxin and Route of Administration
29. Moderate-Intensity Physical Exercise Protects Against Experimental 6-Hydroxydopamine-Induced Hemiparkinsonism Through Nrf2-Antioxidant Response Element Pathway
30. Signaling Mechanisms in the Nitric Oxide Donor- and Amphetamine-Induced Dopamine Release in Mesencephalic Primary Cultured Neurons
31. Exercise Improves Cognitive Impairment and Dopamine Metabolism in MPTP-Treated Mice
32. Spatio-temporal characterization of the pleiotrophinergic system in mouse cerebellum: Evidence for its key role during ontogenesis
33. Divalent Metal Transporter 1 (DMT1) Contributes to Neurodegeneration in Animal Models of Parkinson's Disease
34. Intrastriatal 6-OHDA Lesion Differentially Affects Dopaminergic Neurons in the Ventral Tegmental Area of Prenatally Stressed Rats
35. Six Weeks of Voluntary Exercise don’t Protect C57BL/6 Mice Against Neurotoxicity of MPTP and MPP+
36. Evaluation of Nigrostriatal Neurodegeneration and Neuroinflammation Following Repeated Intranasal 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP) Administration in Mice, an Experimental Model of Parkinson’s Disease
37. MALDI Mass Spectrometry Imaging of 1-Methyl-4-phenylpyridinium (MPP+) in Mouse Brain
38. Counteraction by Nitric Oxide Synthase Inhibitor of Neurochemical Alterations of Dopaminergic System in 6-OHDA-Lesioned Rats Under l-DOPA Treatment
39. Tryptamine-derived alkaloids from Annonaceae exerting neurotrophin-like properties on primary dopaminergic neurons
40. The Chemically-Modified Tetracycline COL-3 and Its Parent Compound Doxycycline Prevent Microglial Inflammatory Responses by Reducing Glucose-Mediated Oxidative Stress
41. HS3ST2 expression is critical for the abnormal phosphorylation of tau in Alzheimer’s disease-related tau pathology
42. Striatal Phosphoproteins in Parkinson Disease and Progressive Supranuclear Palsy
43. Parkin-Knockout Mice did not Display Increased Vulnerability to Intranasal Administration of 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)
44. The non-antibiotic tetracycline COL-3 prevents microglial inflammatory responses by reducing glucose-mediated oxidative stress.
45. Intranasal Administration of Neurotoxicants in Animals: Support for the Olfactory Vector Hypothesis of Parkinson’s Disease
46. New Strategies in Neuroprotection and Neurorepair
47. NON-ANTIBIOTIC DOXYCYCLINE DERIVATIVE AGAINST Α-SYNUCLEIN AGGREGATION
48. EVALUATION OF CANNABIDIOL MODULATION OF DOPAMINE RECEPTOR AND ITS POSSIBLE IMPLICATIONS FOR PARKINSON'S DISEASE
49. CANNABIDIOL AND CANNABIGEROL LIMIT L-DOPA-INDUCED DYSKINESIA WHEN GIVEN SEPARATELY OR IN COMBINATION TO HEMIPARKINSONIAN RATS
50. NEUROPROTECTION OF DOPAMINE NEURONS BY OXYTETRACYCLINE AND ITS NON-ANTIBIOTIC DERIVATIVE DOT IN A CULTURE MODEL OF IRON-DEPENDENT FERROPTOSIS
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.